| # | Drug | Count |
|---|---|---|
| 0 | ENTECAVIR | 7 |
| 1 | LAMIVUDINE | 6 |
| 2 | LAMIVUDINE ORAL | 6 |
| 3 | ADEFOVIR DIPIVOXIL | 4 |
| 4 | DICLOFENAC SODIUM | 4 |
| 5 | TACROLIMUS | 4 |
| 6 | TENOFOVIR DISOPROXIL FUMARATE | 4 |
| 7 | AMLODIPINE | 3 |
| 8 | ENTECAVIR ANHYDROUS | 3 |
| 9 | ISONIAZID | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADEFOVIR DIPIVOXIL | 4 | 0.0031 |
| 1 | TOREMIFENE CITRATE | 1 | 0.0023 |
| 2 | OMEPRAZOLE, SODIUM BICARBONATE | 1 | 0.0010 |
| 3 | STREPTOMYCIN | 1 | 0.0009 |
| 4 | BUFFERED ASPIRIN | 1 | 0.0007 |
| 5 | ENTECAVIR | 7 | 0.0006 |
| 6 | DARUNAVIR ETHANOLATE AND COBICISTAT | 1 | 0.0006 |
| 7 | DEFEROXAMINE MESYLATE | 1 | 0.0005 |
| 8 | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | 1 | 0.0004 |
| 9 | ETHAMBUTOL HYDROCHLORIDE | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 9 | 0.0002 |
| 1 | Bismuth [EPC] | 1 | 0.0002 |
| 2 | Bile Acid [EPC] | 3 | 0.0001 |
| 3 | Antimycobacterial [EPC] | 3 | 0.0001 |
| 4 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0001 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 8 | 0.0001 |
| 6 | Non-narcotic Antitussive [EPC] | 1 | 0.0001 |
| 7 | Cytochrome P450 3A Inhibitor [EPC] | 3 | 0.0000 |
| 8 | Recombinant Human Growth Hormone [EPC] | 1 | 0.0000 |
| 9 | Protease Inhibitor [EPC] | 2 | 0.0000 |